Boston-An injectable tissue-augmenting material is a promising alternativefor the endoscopic treatment of vesicoureteral reflux in children, accordingto researchers from Dublin, Ireland. At follow-up of up to 1 year, refluxwas corrected in 86% of ureters after a single injection of the material,dextranomer/hyaluronic acid copolymer (Deflux, Q-Med, Uppsala, Sweden),according to lead author Prem Puri, MD, pediatric surgeon and director ofresearch at the National Children Hospital in Dublin.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.